$1.42
+0.12 (+8.81%)
Open$1.30
Previous Close$1.31
Day High$1.57
Day Low$1.30
52W High$4.93
52W Low$0.30
Volume—
Avg Volume743.1K
Market Cap7.65M
P/E Ratio—
EPS$-10.37
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.12M | 4.43M | 1.76M |
| Net Income | -123,920,436 | -96,553,019 | -56,960 |
| Profit Margin | -2,421.8% | -2,300.7% | -3.2% |
| EBITDA | -111,990,078 | -92,105,076 | -70,729 |
| Free Cash Flow | — | — | -37,098 |
| Rev Growth | +15.5% | +15.5% | +11.5% |
| Debt/Equity | 0.37 | 0.37 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |